Gene, Oligonucleotide, and Ribozyme Therapy in the Eye
Authors:
- Sudip DasSudip Das
- Keith MillerKMKeith Miller
- 25 March 2003
- book chapter
- Published by Taylor & Francis
- p. 609-661
Abstract
No abstract availableThis publication has 193 references indexed in Scilit:
- Gene Therapy for Ocular DiseaseMolecular Therapy, 2000
- Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheresInternational Journal of Pharmaceutics, 1997
- Bent Pseudoknots and Novel RNA Inhibitors of Type 1 Human Immunodeficiency Virus (HIV-1) Reverse TranscriptaseJournal of Molecular Biology, 1996
- Lipid Membrane Permeability of 2′-Modified Derivatives of Phosphorothioate OligonucleotidesJournal of Pharmaceutical Sciences, 1994
- Retinal light damage: Practical and theoretical considerationsProgress in Retinal and Eye Research, 1994
- Cationic Lipids Improve Antisense Oligonucleotide Uptake and Prevent Degradation in Cultured Cells and in Human SerumBiochemical and Biophysical Research Communications, 1993
- Oligonucleotides encapsulated in pH sensitive liposomes are efficient toward Friend retrovirusBiochemical and Biophysical Research Communications, 1992
- Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulsesEuropean Journal of Cancer and Clinical Oncology, 1991
- Effect of ionic strength on the hybridization of oligodeoxynucleotides with reduced charge due to methylphosphonate linkages to unmodified oligodeoxynucleotides containing the complementary sequenceBiochemistry, 1989
- Electrophoretic mobility of mouse cells and homologous isolated nucleiJournal of Cellular Physiology, 1966